Abnormal Changes in IL-13 and IL-17A Serum Levels in Children with Adenovirus Pneumonia and their Diagnostic Value

Background: Human adenovirus (HAdV) is an enveloped icosahedral DNA virus. HAdV infection can lead to immune system damage, resulting in decreased numbers and compromised function of T cells and B cells. It can also cause an imbalanced Th1/Th2 ratio and dysregulation of pro-inflammatory and anti-inflammatory cytokines.

Objective: To investigate the serum levels of interleukin (IL)-13 and IL-17A in children with HAdV pneumonia.

Methods: Pediatric patients diagnosed with HAdV pneumonia were divided into a non-severe group or a severe group based on the severity of their condition. Patients in the severe group were further classified into good and poor prognosis subgroups. We collected 2-2.5 mL of venous blood from each patient, which was then centrifuged. Using an ELISA detection kit, we determined the concentrations of IL-13 and IL-17A.

Results: Patients with a severe condition exhibited significantly higher serum concentrations of IL-13 and IL-17A than the non-severe cases. Out of 50 severe cases, 32 had good prognoses, while 18 cases showed poor prognoses. Patients with poor prognoses showed significantly higher serum concentrations of IL-13 compared to those with good prognoses.

Conclusion: Serum concentrations of IL-13 and IL-17A are potential diagnostic markers for pediatric patients with severe HAdV pneumonia. Additionally, they demonstrate good predictive value for a poor prognosis in severe pneumonia cases.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:21

Enthalten in:

Iranian journal of immunology : IJI - 21(2024), 1 vom: 12. März, Seite 81-88

Sprache:

Englisch

Beteiligte Personen:

Jiang, Jianbo [VerfasserIn]
Sun, Lili [VerfasserIn]
Huang, Meixia [VerfasserIn]

Links:

Volltext

Themen:

Adenovirus
Cytokines
Interleukin-13
Interleukin-17
Interleukin-17A
Journal Article
Pediatrics
Severe Pneumonia

Anmerkungen:

Date Completed 13.03.2024

Date Revised 13.03.2024

published: Electronic

Citation Status MEDLINE

doi:

10.22034/iji.2024.99509.2648

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368378101